Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
6.57
+0.03 (0.46%)
At close: Oct 30, 2025, 4:00 PM EDT
6.48
-0.09 (-1.37%)
After-hours: Oct 30, 2025, 4:46 PM EDT
Biodesix Revenue
Biodesix had revenue of $20.02M in the quarter ending June 30, 2025, with 11.68% growth. This brings the company's revenue in the last twelve months to $76.56M, up 25.70% year-over-year. In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth.
Revenue (ttm)
$76.56M
Revenue Growth
+25.70%
P/S Ratio
0.63
Revenue / Employee
$280,425
Employees
273
Market Cap
51.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 71.32M | 22.24M | 45.30% |
| Dec 31, 2023 | 49.09M | 10.88M | 28.46% |
| Dec 31, 2022 | 38.21M | -16.29M | -29.89% |
| Dec 31, 2021 | 54.51M | 8.95M | 19.64% |
| Dec 31, 2020 | 45.56M | 21.01M | 85.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BDSX News
- 11 hours ago - Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - GlobeNewsWire
- 8 days ago - Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays - GlobeNewsWire
- 10 days ago - Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 15 days ago - Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting - GlobeNewsWire
- 24 days ago - Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit - GlobeNewsWire
- 7 weeks ago - Biodesix Announces One-for-Twenty Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference - GlobeNewsWire
- 2 months ago - Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewsWire